THE 2-MINUTE RULE FOR AZELAPRAG CLINICAL TRIALS

The biotech sought to bear this mechanism out in STRIDES, a mid-stage, randomized, double-blinded and placebo-controlled demo that evaluated the efficacy and protection of azelaprag—with and with out Eli Lilly’s blockbuster incretin treatment method tirzepatide—in more than 200 individuals with obesity.Potent cytochrome P450 3A4 and/or P-glyc